Search Results - "EXNER, Ruth"
-
1
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
Published in Oncoimmunology (31-12-2023)“…Based upon results of the KEYNOTE-522 trial and following approval by regulatory authorities, the addition of pembrolizumab to chemotherapy is now the…”
Get full text
Journal Article -
2
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Published in Journal of experimental & clinical cancer research (14-11-2023)“…Abstract Background Epirubicin/cyclophosphamide (EC) and docetaxel (D) are commonly used in a sequential regimen in the neoadjuvant treatment of early,…”
Get full text
Journal Article -
3
Ptotic versus Nonptotic Breasts in Nipple-sparing Mastectomy and Immediate Prepectoral Breast Reconstruction
Published in Plastic and reconstructive surgery. Global open (01-05-2023)“…In recent years, nipple-sparing mastectomy followed by implant-based breast reconstruction has gained popularity due to improved cosmetic and psychological…”
Get full text
Journal Article -
4
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
Published in Therapeutic advances in medical oncology (2021)“…Background: Dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and pertuzumab (TP) is a standard therapy of metastatic and…”
Get full text
Journal Article -
5
Optimal duration of adjuvant endocrine therapy: how to apply the newest data
Published in Therapeutic Advances in Medical Oncology (01-11-2017)“…Background: The benefit of 5 years of adjuvant endocrine therapy for women with hormone receptor-positive (HR+) breast cancer (BC) is beyond discussion…”
Get full text
Book Review Journal Article -
6
Regulative potential of glutamine—relation to glutathione metabolism
Published in Nutrition (Burbank, Los Angeles County, Calif.) (01-03-2002)“…Glutamine (GLN) is the most abundant free amino acid (AA) in the human body. Under GLN-free conditions, which can be obtained when cells are cultivated in…”
Get full text
Journal Article Conference Proceeding -
7
Post San Antonio Breast Cancer Symposium 2018: Local and operative therapy, radiotherapy
Published in Memo - Magazine of European medical oncology (01-09-2019)“…Summary This short review summarizes the most important facts presented at the San Antonio Breast Cancer Symposium 2018 concerning local therapy of breast…”
Get full text
Journal Article -
8
Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Systemic Review and Meta-analysis
Published in Annals of surgical oncology (01-01-2023)“…Background Implant-based breast reconstruction (IBBR) remains the standard and most popular option for women undergoing breast reconstruction after mastectomy…”
Get full text
Journal Article -
9
Local therapies for breast cancer
Published in Memo - Magazine of European medical oncology (2017)“…Summary During the San Antonio Breast Cancer Symposium in December 2016, the main topics were systemic treatment of breast cancer and molecular research. But…”
Get full text
Journal Article -
10
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Published in The lancet oncology (01-03-2019)“…In postmenopausal women with hormone receptor-positive, early-stage breast cancer, treatment with adjuvant aromatase inhibitors is the standard of care, but it…”
Get full text
Journal Article -
11
-
12
Review: Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?
Published in Therapeutic Advances in Medical Oncology (01-11-2009)“…Recent advances in the treatment of early breast cancer have improved clinical outcomes and prolonged survival, especially in women with endocrine-responsive…”
Get full text
Book Review Journal Article -
13
The Impact of Adjuvant Radiotherapy on Immediate Prepectoral Implant-Based Breast Reconstruction
Published in Aesthetic plastic surgery (01-07-2024)“…Background Immediate prepectoral implant-based breast reconstruction (IBBR) rates have increased in recent years owing to improved cosmetic and psychological…”
Get full text
Journal Article -
14
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Published in The Lancet (British edition) (01-08-2015)“…Summary Background Adjuvant endocrine therapy compromises bone health in patients with breast cancer, causing osteopenia, osteoporosis, and fractures…”
Get full text
Journal Article -
15
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
Published in Cancer discovery (01-02-2022)“…Personalized medicine aims to match the right drug with the right patient by using specific features of the individual patient's tumor. However, current…”
Get more information
Journal Article -
16
Differential effects of epirubicin and docetaxel on the immune system in patients with breast cancer (BC)
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 588 Background: Neoadjuvant chemotherapy (NAC) with epirubicin/cyclophosphamid (EC) followed by docetaxel (D) is currently a standard of care…”
Get full text
Journal Article -
17
Abstract P1-02-06: Prediction of Prosigna® breast cancer intrinsic subtype by immunohistochemical ER, PR and Ki67 expression
Published in Cancer research (Chicago, Ill.) (15-02-2022)“…Abstract The present study evaluated whether Prosigna® breast cancer assay intrinsic subtype (IST) can be predicted using a specified cutoff for Ki67…”
Get full text
Journal Article -
18
Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials
Published in Breast cancer research and treatment (01-07-2017)“…Purpose Objective cosmetic analysis is important to evaluate the cosmetic outcome after breast surgery or breast radiotherapy. For this purpose, we aimed to…”
Get full text
Journal Article -
19
Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases
Published in Clinical cancer research (01-05-2019)“…Brain metastases (BMs) are a rare but devastating condition in estrogen receptor (ER)-positive metastatic breast cancer (MBC). Although endocrine therapy (ET)…”
Get full text
Journal Article -
20
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
Published in European journal of cancer (1990) (01-06-2020)“…Immune-based strategies represent a promising approach in breast cancer (BC) treatment. The glycoprotein mucin-1 (MUC-1) is overexpressed in more than 90% of…”
Get full text
Journal Article